Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of inhaled verapamil in COPD
IRCT20170210032478N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of verapamil in chronic obstructive pulmonary disease (COPD), sponsored by Tehran University of Medical Sciences. Started Jul 2018; status: completed.
02
Drugs
verapamil
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20170210032478N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170210032478N2.